Novartis Says Half Dose of H1N1 Vaccine Sufficient

Novarits (NVS) said today a US clinical study showed a half dose of its H1N1 vaccine may be enoug...  More »

Novarits (NVS) said today a US clinical study showed a half dose of its H1N1 vaccine may be enough to protect recipients from the flu. A trial of 4,000 people showed a half dose gives adults immunity to the swine flu.  « Less